De Maeyer-Guignard J - Search Results

1

De Maeyer E, De Maeyer-Guignard J. De Maeyer E, et al. Among authors: de maeyer guignard j. Curr Opin Immunol. 1992 Jun;4(3):321-6. doi: 10.1016/0952-7915(92)90083-q. Curr Opin Immunol. 1992. PMID: 1418712 Review.

2

Exploring interferon beta for gene therapy of HIV infection.

Lauret E, Vieillard V, Rousseau V, De Maeyer-Guignard J, De Maeyer E. Lauret E, et al. Among authors: de maeyer guignard j. Res Immunol. 1994 Oct-Dec;145(8-9):674-7; discussion 677-8. doi: 10.1016/s0923-2494(05)80053-7. Res Immunol. 1994. PMID: 7754218 Review. No abstract available.

3

Type I interferons.

De Maeyer E, De Maeyer-Guignard J. De Maeyer E, et al. Among authors: de maeyer guignard j. Int Rev Immunol. 1998;17(1-4):53-73. doi: 10.3109/08830189809084487. Int Rev Immunol. 1998. PMID: 9914943 Review.

4

Linkage analysis of the Gi alpha 2 gene on mouse chromosome 9.

De Maeyer-Guignard J, De Maeyer E. De Maeyer-Guignard J, et al. Mamm Genome. 1992;3(10):601-3. doi: 10.1007/BF00350628. Mamm Genome. 1992. PMID: 1421769 No abstract available.

5

The growth rate of two transplantable murine tumors, 3LL lung carcinoma and B16F10 melanoma, is influenced by Hyal-1, a locus determining hyaluronidase levels and polymorphism.

De Maeyer E, De Maeyer-Guignard J. De Maeyer E, et al. Among authors: de maeyer guignard j. Int J Cancer. 1992 Jun 19;51(4):657-60. doi: 10.1002/ijc.2910510425. Int J Cancer. 1992. PMID: 1601526

6

Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment.

Seif I, De Maeyer E, Riviere I, De Maeyer-Guignard J. Seif I, et al. J Virol. 1991 Feb;65(2):664-71. doi: 10.1128/JVI.65.2.664-671.1991. J Virol. 1991. PMID: 1846190 Free PMC article.

7

You cannot get away from interferon.

De Maeyer E, De Maeyer-Guignard J. De Maeyer E, et al. J Interferon Res. 1987 Oct;7(5):467-70. doi: 10.1089/jir.1987.7.467. J Interferon Res. 1987. PMID: 2445842 No abstract available.

8

Identification by in situ hybridization of IFN-beta-producing murine macrophages obtained from high and low interferon producers.

De Maeyer-Guignard J, Marcucci F, De Maeyer E. De Maeyer-Guignard J, et al. Ann Inst Pasteur Virol. 1988 Jan-Mar;139(1):51-7. doi: 10.1016/s0769-2617(88)80005-4. Ann Inst Pasteur Virol. 1988. PMID: 3207503

9

Stable antiviral expression (SAVE) as an approach to somatic cell gene therapy directed against HIV infection.

De Maeyer E, Seif I, Vieillard V, Cases O, Rousseau V, De Maeyer-Guignard J, Lauret E. De Maeyer E, et al. Among authors: de maeyer guignard j. Hokkaido Igaku Zasshi. 1994 Nov;69(6):1288-93. Hokkaido Igaku Zasshi. 1994. PMID: 7705744 Review.

10

Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells.

Lauret E, Riviere I, Rousseau V, Vieillard V, De Maeyer-Guignard J, De Maeyer E. Lauret E, et al. Among authors: de maeyer guignard j. Hum Gene Ther. 1993 Oct;4(5):567-77. doi: 10.1089/hum.1993.4.5-567. Hum Gene Ther. 1993. PMID: 8280795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page